Page last updated: 2024-08-18

cyclohexanol and Syndrome

cyclohexanol has been researched along with Syndrome in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (57.14)18.2507
2000's3 (21.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oliveira, L; Salgado, A; Salgado, JV; Sierra-Siegert, M1
Davis, E; Egerdie, B; Evans, R; Mackenzie, L; Nickel, JC; Shrewsbury, SB1
Chan, JH; Chen, CH; Robson, D; Tan, HK1
Capua, AD; Castrogiovanni, A; Ciani, V; Lazzeri, L; Luisi, S; Pacchierotti, C; Pasquini, R; Petraglia, F1
Lurie, SD; Makari-Judson, G; Reuben, SS1
Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM1
Arnecke, B; Guidry, JR; Heisler, MA1
Gitlin, MJ1
Hodgman, MJ; Krenzelok, EP; Martin, TG1
Kolecki, P1
Adès, J; Lejoyeux, M1
Haddad, P1
Mekler, G; Woggon, B1
Machado, JF; Roxanas, MG1

Reviews

2 review(s) available for cyclohexanol and Syndrome

ArticleYear
Antidepressant discontinuation: a review of the literature.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride

1997
Newer antidepressants and the discontinuation syndrome.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7

    Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride

1997

Trials

3 trial(s) available for cyclohexanol and Syndrome

ArticleYear
A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    The Journal of urology, 2016, Volume: 196, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclohexanols; Cystitis, Interstitial; Cystoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Urinary Bladder; Young Adult

2016
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Climacteric; Cyclohexanols; Drug Repositioning; Female; Humans; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride

2012
Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome.
    Journal of pain and symptom management, 2004, Volume: 27, Issue:2

    Topics: Analgesics; Cyclohexanols; Female; Humans; Mastectomy; Middle Aged; Pain Measurement; Pain, Postoperative; Perioperative Care; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride

2004

Other Studies

9 other study(ies) available for cyclohexanol and Syndrome

ArticleYear
Depersonalization and derealization syndrome: report on a case study and pharmacological management.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2012, Volume: 34, Issue:4

    Topics: Adult; Cyclohexanols; Depersonalization; Female; Humans; Lamotrigine; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Triazines; Venlafaxine Hydrochloride

2012
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Syndrome; Venlafaxine Hydrochloride

2009
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:5

    Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders

2007
Serotonin syndrome induced by administration of venlafaxine and phenelzine.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:1

    Topics: Antidepressive Agents; Central Nervous System Diseases; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Syndrome; Venlafaxine Hydrochloride

1996
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1

    Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride

1997
Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy.
    Human & experimental toxicology, 1997, Volume: 16, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Coma; Cyclohexanols; Drug Interactions; Female; Fever; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Tranylcypromine; Venlafaxine Hydrochloride

1997
Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks.
    Journal of toxicology. Clinical toxicology, 1997, Volume: 35, Issue:2

    Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride

1997
A case of serotonin syndrome caused by venlafaxine and lithium.
    Pharmacopsychiatry, 1997, Volume: 30, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanols; Drug Interactions; Female; Humans; Lithium Compounds; Middle Aged; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride

1997
Serotonin syndrome in combined moclobemide and venlafaxine ingestion.
    The Medical journal of Australia, 1998, May-18, Volume: 168, Issue:10

    Topics: Adult; Benzamides; Central Nervous System Depressants; Cyclohexanols; Drug Interactions; Drug Overdose; Ethanol; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride

1998